查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1758898

全球心房顫動手術市場

Atrial Fibrillation Surgery
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球心房顫動手術市場規模將達到 53 億美元

全球心房顫動手術市場規模預計在2024年為23億美元，到2030年將達到53億美元，在分析期間（2024-2030年）的複合年成長率為14.8%。心導管電氣燒灼術是本報告分析的細分市場之一，預計其複合年成長率為16.7%，到分析期結束時規模將達到37億美元。外科消融術細分市場在分析期間的複合年成長率預計為11.1%。

美國市場規模估計為 6.355 億美元，中國市場預計複合年成長率為 20.0%

美國心房顫動手術市場規模預計在2024年達到6.355億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到12億美元，在2024-2030年的分析期間內，複合年成長率為20.0%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為10.7%和13.4%。在歐洲，預計德國市場的複合年成長率為11.8%。

全球心房顫動手術市場－主要趨勢與促進因素摘要

為什麼手術在心房顫動治療中變得越來越重要？

心房顫動 (AF) 是一種常見的心律不整，由於其與中風、心臟衰竭以及整體疾病的關聯性，日益加重了人們的健康負擔。雖然包括抗凝血劑和抗心律不整藥物在內的藥物治療在治療中仍發揮重要作用，但手術治療已成為長期心律控制的主要手段，尤其對於持續性或難治性心房顫動患者。這種轉變源於藥物治療的局限性，這些藥物通常存在副作用、症狀控制不充分以及療效隨時間推移而遞減等問題。隨著老化以及高血壓、肥胖和糖尿病等疾病的流行，全球心房顫動發病率不斷上升，手術治療已成為更可靠、更永續的解決方案。越來越多的臨床證據支持手術的有效性，使其更具吸引力，尤其是在降低復發率和改善生活品質方面。同時，術中標測、影像和消融工具的進步顯著改善了手術效果。越來越多的患者正在更早接受手術，尤其是在藥物治療無法提供足夠療效的情況下。人口結構的變化、手術安全性的提高以及長期有效性的結合使得心房顫動手術不再只是最後的手段，而是全面節律管理策略的核心組成部分。

技術突破如何影響現代心房顫動手術？

外科手術技巧和技術的演變在重新定義心房顫動手術領域方面發揮了重要作用。從歷史上看，像 Cox-Maze 手術這樣的手術被認為是高度有效的，但由於其侵入性大且需要開胸手術，其效果有限。如今，該領域正在經歷模式轉移，轉向微創混合手術，將手術和導管方法結合，精確度更高，患者風險更低。射頻、冷凍消融術以及最近的高強度聚焦超音波等能量消融治療方法的採用，使外科醫生能夠更精確地創建經皮病變並縮短手術時間。這些治療方法由即時電生理學定位和 3D視覺化系統支持，可在手術期間提供全面指導。此外，機器人輔助手術的創新提高了靈活性和可視性，可以透過小切口進行複雜的操作，從而縮短恢復時間。事實證明，將心外膜手術消融術與心內膜心導管電氣燒灼術相結合的混合手術對持續性心房顫動和長期持續性心房顫動病例尤其有效。這些手術可以使病變組覆蓋導管無法單獨到達的區域。此外，人工智慧和機器學習的整合正開始影響手術計劃，透過幫助確定針對個體解剖和電生理特徵的最佳消融策略。這些進展顯著擴展了手術選擇的範圍和安全性，使其對尋求長期心律矯正解決方案的臨床醫生和患者都具有吸引力。

哪些外在因素支持了心房顫動手術治療的需求？

心房顫動外科治療的需求不僅受到醫療創新的影響，也受到更廣泛的製度和社會因素的影響。其中一個重要的影響因素是醫療保健模式轉向積極主動、以結果主導的治療模式的轉變。在許多地區，醫療保健系統正在獎勵那些能夠降低長期住院率和復發性干預的手術，使心房顫動手術成為符合條件的患者的一種經濟有效的治療選擇。此外，尤其是在新興國家，公立和私立醫院外科手術的普及程度不斷提高，改善了先前受地域或成本限制的患者獲得醫療服務的機會。循環系統學會和病患權益組織所進行的宣傳宣傳活動也在向大眾和轉診醫師宣傳早期外科手術的益處方面發揮著重要作用。醫療培訓計畫也在不斷發展，越來越多的心臟外科醫生接受了先進消融技術和微創策略的培訓，這有助於克服先前手術可及性的限制。外科心房顫動治療的保險覆蓋範圍也逐漸擴大，尤其是在現實世界數據證明了其成本效益的情況下。另一個重要因素是患者主導的轉變。許多患者現在正在尋求長期的非藥物治療方案，以減少對藥物的依賴並改善生活品質。同時，穿戴式裝置和遠端監控的廣泛使用使得能夠更早發現無症狀性或間歇性心房顫動，從而擴大了手術干預的候選範圍。這些外部因素共同推動了心房顫動手術市場手術數量和技術創新投資的穩定成長。

推動心房顫動手術市場成長的關鍵因素有哪些？

心房顫動手術市場的成長受到人口、技術、臨床和機構發展等多個關鍵因素的驅動。首先，全球人口老化是主要因素。心房顫動的盛行率隨著年齡的成長而顯著增加，因此需要高階心律控制介入的患者數量也隨之增加。此外，高血壓、冠狀動脈疾病和睡眠呼吸中止症等併發症的發生率也急劇上升，這些併發症與心房顫動的發生發展密切相關。這些因素使心房顫動的治療變得更加複雜，也增加了對手術等更精準治療方法的需求。從技術角度來看，以即時映射系統和能量消融工具為支撐的微創技術的改進，使手術更加安全、方便和有效。臨床醫生對該手術的長期成功充滿信心，尤其是採用同時處理兩個心房平面的混合手術，這使得手術在各個治療中心得到了更廣泛的應用。從醫療服務的角度來看，報銷政策的完善以及人們對外科手術成本效益的日益重視，使得這些手術對患者和醫療服務提供者更具經濟可行性。此外，醫院正在投資專業的電生理科室和外科基礎設施，以滿足日益成長的手術需求。最後，患者的期望也在改變；他們變得越來越精明和積極主動，減少了對長期藥物治療的依賴，並尋求能夠帶來永續療效的治療方案。這些因素共同塑造了一個充滿活力的環境，使心房顫動手術市場在臨床需求和不斷發展的醫療生態系統的推動下，實現持續強勁的成長。

部分

產品（心導管電氣燒灼術、手術消融）

受訪企業範例（共42家）

  • Abbott Laboratories
  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Biosense Webster Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • CardioFocus Inc.
  • Endoscopic Technologies Inc.
  • Johnson & Johnson
  • Kardium Inc.
  • Koninklijke Philips NV
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Ncontact Inc.
  • OSYPKA AG
  • Sanofi-Aventis
  • Siemens Healthineers AG

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競賽

簡介目錄
Product Code: MCP36223

Global Atrial Fibrillation Surgery Market to Reach US$5.3 Billion by 2030

The global market for Atrial Fibrillation Surgery estimated at US$2.3 Billion in the year 2024, is expected to reach US$5.3 Billion by 2030, growing at a CAGR of 14.8% over the analysis period 2024-2030. Catheter Ablation, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Surgical Ablation segment is estimated at 11.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$635.5 Million While China is Forecast to Grow at 20.0% CAGR

The Atrial Fibrillation Surgery market in the U.S. is estimated at US$635.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 20.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 10.7% and 13.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11.8% CAGR.

Global Atrial Fibrillation Surgery Market - Key Trends & Drivers Summarized

Why Is Surgical Intervention Becoming Increasingly Central in Atrial Fibrillation Management?

Atrial fibrillation (AF), a common type of cardiac arrhythmia, has become a growing health burden due to its association with stroke, heart failure, and overall cardiovascular morbidity. While medical management, including anticoagulants and antiarrhythmic drugs, continues to play an important role in treatment, surgical intervention is becoming increasingly central to long-term rhythm control, particularly for patients with persistent or refractory AF. This shift stems from the limitations of pharmacological therapies, which often present issues related to side effects, inadequate symptom control, or diminishing efficacy over time. As the global incidence of AF rises-fueled by an aging population and the prevalence of conditions such as hypertension, obesity, and diabetes-clinicians are turning to surgical procedures as a more definitive and sustainable solution. The growing body of clinical evidence supporting the efficacy of surgical techniques, especially in reducing recurrence rates and improving quality of life, has strengthened their appeal. In parallel, advancements in intraoperative mapping, imaging, and ablation tools have significantly improved surgical outcomes. Patients are increasingly being referred for surgery earlier in their disease course, especially when medical therapy fails to offer adequate relief. The combination of demographic shifts, improved procedural safety, and long-term efficacy is positioning AF surgery not merely as a last resort, but as a core component of a comprehensive rhythm management strategy.

How Are Technological Breakthroughs Shaping the Modern AF Surgery Landscape?

The evolution of surgical techniques and technologies has played a transformative role in redefining the atrial fibrillation surgery landscape. Historically, procedures like the Cox-Maze surgery were considered highly effective but were limited by their invasiveness and the need for open-heart access. Today, the field has seen a paradigm shift toward minimally invasive and hybrid procedures that blend surgical and catheter-based approaches for better precision and lower patient risk. The adoption of energy-based ablation modalities-such as radiofrequency, cryoablation, and more recently, high-intensity focused ultrasound-has allowed surgeons to create transmural lesions with greater accuracy and reduced procedural time. These modalities are supported by real-time electrophysiological mapping and 3D visualization systems, which provide comprehensive guidance throughout the operation. Furthermore, innovations in robotic-assisted surgery have enhanced dexterity and visualization, enabling complex maneuvers through small incisions and leading to faster recovery times. Hybrid procedures that combine epicardial surgical ablation with endocardial catheter ablation are proving especially effective for persistent and long-standing persistent AF cases. These techniques allow for lesion sets that address areas inaccessible by catheter alone. Additionally, the integration of artificial intelligence and machine learning is starting to influence surgical planning by helping identify optimal ablation strategies tailored to individual anatomical and electrical profiles. These advancements have significantly expanded the scope and safety of surgical options, making them more appealing to both clinicians and patients seeking a long-term solution for rhythm correction.

What External Dynamics Are Steering the Demand for AF Surgical Procedures?

The demand for atrial fibrillation surgical interventions is shaped not only by medical innovation but also by broader systemic and societal factors. One significant influence is the shifting healthcare paradigm toward proactive and outcome-driven interventions. In many regions, healthcare systems are incentivizing procedures that reduce long-term hospitalization rates and recurrent interventions, which positions AF surgery as a cost-effective option for appropriately selected patients. Moreover, the increased availability of surgical services in both public and private hospitals, especially in emerging economies, has improved access to care for patients previously limited by geography or cost constraints. Awareness campaigns by cardiology societies and patient advocacy groups have also played a crucial role in educating the public and referring physicians about the benefits of early surgical intervention. Medical training programs are evolving as well, with more cardiac surgeons being trained in advanced ablation techniques and minimally invasive strategies, helping to overcome earlier limitations related to procedural availability. Insurance coverage for surgical AF treatments is gradually expanding, especially as real-world data demonstrate their cost-effectiveness over time. Another significant factor is the patient-driven shift in preferences-many individuals now seek long-term, non-pharmacological solutions that reduce medication dependency and improve quality of life. In parallel, the increasing use of wearable devices and remote monitoring has led to earlier detection of asymptomatic or intermittent AF, which broadens the candidate pool for surgical intervention. Collectively, these external forces are driving a steady rise in both procedural volumes and innovation investment within the AF surgical market.

What Are the Primary Drivers Fueling Growth in the Atrial Fibrillation Surgery Market?

The growth in the atrial fibrillation surgery market is driven by several key factors rooted in demographic, technological, clinical, and institutional developments. First, the aging global population is a major contributor, as AF prevalence increases significantly with age, creating a larger pool of patients requiring advanced rhythm control interventions. In addition, there is an upsurge in co-morbid conditions such as hypertension, coronary artery disease, and sleep apnea, which are closely linked to the onset and progression of atrial fibrillation. These factors increase the complexity of disease management and elevate the demand for more definitive treatment options such as surgery. Technologically, the refinement of minimally invasive techniques, supported by real-time mapping systems and energy-based ablation tools, has made surgery safer, more accessible, and more effective. Clinician confidence in the long-term success of procedures-particularly hybrid approaches that address both atrial surfaces-has led to broader adoption across treatment centers. From a healthcare delivery standpoint, improved reimbursement policies and growing recognition of the cost-benefit profile of surgical interventions are making these procedures more financially viable for both patients and providers. Additionally, hospitals are investing in specialized electrophysiology units and surgical infrastructure to meet rising procedural demand. Finally, patient expectations are changing; individuals are increasingly informed and proactive, seeking out options that offer lasting results with reduced reliance on long-term medications. These combined drivers are creating a dynamic environment where the atrial fibrillation surgery market is poised for sustained and robust growth, supported by both clinical necessity and evolving healthcare ecosystems.

SCOPE OF STUDY:

The report analyzes the Atrial Fibrillation Surgery market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Catheter Ablation, Surgical Ablation)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AtriCure Inc.
  • BIOTRONIK SE & Co. KG
  • Biosense Webster Inc.
  • Boehringer Ingelheim GmbH
  • Boston Scientific Corporation
  • Bristol-Myers Squibb Company
  • CardioFocus Inc.
  • Endoscopic Technologies Inc.
  • Johnson & Johnson
  • Kardium Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical Technology Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • MicroPort Scientific Corporation
  • Ncontact Inc.
  • OSYPKA AG
  • Sanofi-Aventis
  • Siemens Healthineers AG

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Atrial Fibrillation Surgery - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Atrial Fibrillation Spurs Demand for Surgical Interventions
    • Increased Focus on Minimally Invasive Procedures Drives Adoption of Advanced Surgical Techniques
    • Boom in Aging Populations and Comorbidities Expands the Addressable Market for Atrial Fibrillation Surgery
    • Growing Emphasis on Long-term Rhythm Control Throws the Spotlight on Surgical Ablation Options
    • Advances in Energy Sources and Mapping Technologies Propel Innovation in Surgical Outcomes
    • Demand for Hybrid Procedures Combining Catheter and Surgical Approaches Strengthens Treatment Adoption
    • Here's How Early Diagnosis and Risk Stratification Accelerate Surgical Referrals
    • Wider Integration of Robotic-assisted Surgery Generates Precision and Reduced Recovery Times
    • Rising Surgical Volumes in High-risk Patient Groups Sustain Market Growth
    • Expansion of Electrophysiology Programs and Specialized Cardiac Centers Unlocks New Access Points
    • Growing Evidence Supporting Surgical Efficacy Fuels Clinical Guidelines and Physician Confidence
    • Increased Focus on Post-operative Monitoring and Recurrence Prevention Shapes Adjunct Therapy Demand
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Atrial Fibrillation Surgery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Atrial Fibrillation Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Catheter Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Catheter Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Catheter Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Surgical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Surgical Ablation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Surgical Ablation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 11: USA Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 12: USA Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 13: USA 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 14: Canada Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 15: Canada Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 16: Canada 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • JAPAN
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 17: Japan Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Japan Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 19: Japan 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • CHINA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 20: China Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: China Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 22: China 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • EUROPE
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 23: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: Europe Historic Review for Atrial Fibrillation Surgery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 25: Europe 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • FRANCE
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 29: France Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: France Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 31: France 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • GERMANY
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 32: Germany Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Germany Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 34: Germany 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 35: Italy Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Italy Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 37: Italy 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 38: UK Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: UK Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 40: UK 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 41: Spain Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Spain Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 43: Spain 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 44: Russia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Russia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 46: Russia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 56: Australia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Australia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 58: Australia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • INDIA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 59: India Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: India Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 61: India 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 62: South Korea Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: South Korea Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 64: South Korea 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 65: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Rest of Asia-Pacific Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 67: Rest of Asia-Pacific 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 68: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 69: Latin America Historic Review for Atrial Fibrillation Surgery by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 70: Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 73: Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 74: Argentina Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Argentina Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 76: Argentina 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 77: Brazil Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Brazil Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 79: Brazil 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 80: Mexico Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Mexico Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 82: Mexico 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 83: Rest of Latin America Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Latin America Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 85: Rest of Latin America 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 86: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Middle East Historic Review for Atrial Fibrillation Surgery by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 88: Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 91: Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 92: Iran Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Iran Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 94: Iran 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 95: Israel Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Israel Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 97: Israel 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 98: Saudi Arabia Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Saudi Arabia Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 100: Saudi Arabia 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 101: UAE Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: UAE Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 103: UAE 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 104: Rest of Middle East Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Middle East Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 106: Rest of Middle East 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030
  • AFRICA
    • Atrial Fibrillation Surgery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 107: Africa Recent Past, Current & Future Analysis for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Africa Historic Review for Atrial Fibrillation Surgery by Product - Catheter Ablation and Surgical Ablation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
    • TABLE 109: Africa 16-Year Perspective for Atrial Fibrillation Surgery by Product - Percentage Breakdown of Value Sales for Catheter Ablation and Surgical Ablation for the Years 2014, 2025 & 2030

IV. COMPETITION